secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001437749-24-021296
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma annual meeting elects all directors, ratifies auditor, approves say-on-pay
--------------------------------------------------------------------------------

- All five incumbent directors elected with majority votes; Joshua Disbrow received 2,111,846 for, 596,291 withheld.
- Ratification of Grant Thornton as auditor for FY 2024 approved: 3,290,868 for, 683,165 against.
- Non-binding advisory vote on executive compensation approved: 1,978,765 for, 659,394 against.
- Quorum of 73% (4,037,162 shares) represented at the June 26, 2024 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000143774924021296/0001437749-24-021296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000143774924021296/aytu20240607_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-021296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer